- Home
- HOWL vs UAMY Comparison
HOWL vs UAMY Comparison
Compare HOWL & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOWL | UAMY |
|---|---|---|
| Founded | 2017 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.5M | 829.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOWL | UAMY |
|---|---|---|
| Price | $0.67 | $5.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $6.50 | $5.69 |
| AVG Volume (30 Days) | 796.4K | ★ 7.8M |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $31,857,819.00 |
| Revenue This Year | N/A | $159.13 |
| Revenue Next Year | N/A | $228.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 177.97 |
| 52 Week Low | $0.56 | $1.21 |
| 52 Week High | $2.38 | $19.71 |
Technical Indicators
Market Signals| Indicator | HOWL | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 31.60 | 45.97 |
| Support Level | $0.56 | $4.36 |
| Resistance Level | $1.20 | $5.08 |
| Average True Range (ATR) | 0.10 | 0.57 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 17.25 | 47.98 |
Price Performance
Historical ComparisonAbout HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.